false
ar,be,bn,zh-CN,zh-TW,en,fr,de,hi,it,ja,ko,pt,ru,es,sw,vi
Catalog
Didactics
Neo-adjuvant Chemotherapy in Malignant Ovarian Ger ...
Neo-adjuvant Chemotherapy in Malignant Ovarian Germ Cell Tumors
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The video transcript discusses the effectiveness of neoadjuvant chemotherapy in treating malignant ovarian germ cell tumors, particularly focusing on young females. Prior to the use of chemotherapy, prognosis was poor, but now with improved treatments, the five-year survival rate has exceeded 85%. Neoadjuvant chemotherapy followed by fertility-sparing surgery has shown positive outcomes, with high survival rates in certain tumor types. The study emphasized the importance of preserving fertility in these patients. Overall, neoadjuvant chemotherapy has proven to be beneficial in treating advanced stage ovarian germ cell tumors while maintaining oncologic outcomes and fertility options.
Asset Subtitle
Pabrita Maharjan, Poonam Lama, Jitendra Pariyar
February 2024
Keywords
neoadjuvant chemotherapy
malignant ovarian germ cell tumors
young females
fertility-sparing surgery
five-year survival rate
Contact
education@igcs.org
for assistance.
×